Opiate Pharmaceuticals Private Limited
About Opiate Pharmaceuticals Private Limited
Data last updated:
Opiate Pharmaceuticals Private Limited is a private limited company based in Kothamangalam, Kerala, India. It was incorporated on 06 November 2023.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U46497KL2023PTC084389.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹90,000. It is led by directors Renjith Sasidharan Nair and Tony Joseph.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kothamangalam, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.58 Lakh. For the same year it recorded a net loss of ₹2.04 Lakh (net margin -14%) and EBITDA of -₹2.04 Lakh (EBITDA margin -14%).
Company details
Contact details
Opiate Pharmaceuticals Private Limited's registered office is in Kothamangalam, Kerala.
- Registered Address162 – A, Velloorkunnath Building, Kothamangalam, Kerala, India – 686691
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Opiate Pharmaceuticals Private Limited
FY 2025 filings availableOpiate Pharmaceuticals Private Limited reported revenue of ₹14.58 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹2.04 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹2.04 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -14% | |
| Net Profit Margin | -14% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Opiate Pharmaceuticals Private Limited, buy the company report.
Board of directors of Opiate Pharmaceuticals Private Limited
Opiate Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renjith Sasidharan Nair | Director | 06 Nov 2023 | 2 Years 11 Months | Current |
| Tony Joseph | Director | 20 Jan 2025 | 1 Years 9 Months | Current |
Peer comparison
Opiate Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vibzoe Pharmaceuticals India Private Limited | ₹14.73 Lakh (FY 2025) | -10.0% | Kollam, Kerala, India | |||
| Aariv Pharmaceuticals Private Limited | ₹14.71 Lakh (FY 2022) | Ankleshwar, Gujarat, India | ||||
| Avitsan Pharmaceuticals Private Limited | ₹14.64 Lakh (FY 2025) | -6.0% | Valsad, Gujarat, India | |||
| Sanvita Pharmaceuticals Private Limited | ₹14.62 Lakh (FY 2018) | 225.0% | Motihari, Bihar, India | |||
| Praval Pharmaceuticals Private Limited | ₹14.59 Lakh (FY 2025) | -7.0% | Chennai, Tamil Nadu, India | |||
| Opiate Pharmaceuticals Private Limitedthis company | ₹14.58 Lakh (FY 2025) | -₹2.04 Lakh | -14% | Kothamangalam, Kerala, India | ||
| Pharmonix Pharmaceuticals Private Limited | ₹14.53 Lakh (FY 2019) | 27.0% | Bhuaneswar, Odisha, India | |||
| AI Di Pharmaceuticals Private Limited | ₹14.49 Lakh (FY 2024) | 93.0% | Delhi, India | |||
| Anovikan Pharmaceuticals Private Limited | ₹14.45 Lakh (FY 2025) | 32.0% | New Delhi, Delhi, India | |||
| Acculife Pharmaceuticals Private Limited | ₹14.42 Lakh (FY 2024) | 17.0% | Jalna, Maharashtra, India | |||
| Elinza Pharmaceuticals Private Limited | ₹14.42 Lakh (FY 2025) | 17.0% | Chandigarh, India |
To see the full peer comparison of Opiate Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Opiate Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Opiate Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Opiate Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Opiate Pharmaceuticals Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Sukumaran Maliyeckal Sumesh ceased to be Director on 20 Jan 2025.
Frequently asked questions
Opiate Pharmaceuticals is an active private limited company based in Kothamangalam, Kerala, India. It was incorporated on 06 November 2023 (3+ years old) and is registered under CIN U46497KL2023PTC084389.
Opiate Pharmaceuticals has 2 current directors:
- Renjith Sasidharan Nair - Director
- Tony Joseph - Director
The latest financial statements of Opiate Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Opiate Pharmaceuticals is U46497KL2023PTC084389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Opiate Pharmaceuticals was incorporated on 06 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Opiate Pharmaceuticals by revenue are Vibzoe Pharmaceuticals India Private Limited, Aariv Pharmaceuticals Private Limited, Avitsan Pharmaceuticals Private Limited, Sanvita Pharmaceuticals Private Limited, Praval Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Sukumaran Maliyeckal Sumesh ceased to be Director on 20 Jan 2025. Tony Joseph was appointed as Director on 20 Jan 2025. Renjith Sasidharan Nair was appointed as Director on 06 Nov 2023. Opiate Pharmaceuticals has 4 board changes on record in total.
The registered office of Opiate Pharmaceuticals is at 162 – A, Velloorkunnath Building, Kothamangalam, Kerala, India – 686691.
Opiate Pharmaceuticals can be reached at its registered office: 162 – A, Velloorkunnath Building, Kothamangalam, Kerala, India – 686691.
Opiate Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Ernakulam.